Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ARCH Venture Partners
Biotech
Boundless Bio bumps IPO market back to life
Boundless Bio is going public a month after launching its second asset into the clinic.
Max Bayer
Mar 6, 2024 5:20pm
VC investment in biopharma dropped nearly $7B in 2023: PitchBook
Mar 5, 2024 5:00am
Neumora files for IPO to fund phase 3 depression clinical trials
Aug 28, 2023 9:40am
Nutcracker lays off a dozen staffers after $167M round in 2022
Jun 21, 2023 1:43pm
Orbital raises $270M for next-gen RNA meds, loops in 2 new execs
Apr 26, 2023 6:00am
FogPharma hauls in $178M series D
Nov 21, 2022 4:33pm